Dr. Ingmar Gorman is a psychologist who specializes in assisting populations who have had experiences with psychedelics and other psychoactive compounds. He is the Administrative Director of the Psychedelic Education and Continuing Care Program at the Center for Optimal Living, where he leads groups, trainings, and works with individual clients. Additionally, Dr. Gorman has extensive training in treating substance misuse, drawing upon mentorship by Dr. Andrew Tatarsky and Dr. Jen Talley, in Harm Reduction Psychotherapy and Mindfulness based approaches. Dr. Gorman received his PhD in clinical psychology from the New School for Social Research. He completed his internship at Bellevue Hospital Center and is currently an NIH funded postdoctoral fellow at New York University’s Behavioral Sciences Training in Drug Abuse Research Program (BST), which is NIDA’s largest and longest-standing training program. Dr. Gorman is also site co-principal investigator and therapist on a Phase 3 clinical trial studying the potential psychotherapeutic utility of MDMA for post-traumatic stress disorder.
Specialties: Integrative Harm Reduction Psychotherapy, Substance Use Treatment, Trauma, Psychedelic Psychotherapy and Integration
Learning from the Unforeseen: Lessons in Psychedelic Integration Therapy
What happens when the wish from a psychedelic experience doesn’t come true? Or when someone is left in great distress as a consequence? How do we respond as individuals, as therapists, and as a community? Is there such a thing as psychedelic induced trauma? This very question challenges us and our sense of legitimacy, but it’s a question we must shed light on. We will grapple with these questions by reviewing reports of individuals troubled after using a psychedelic experience and insights from clinical practice.